Rebecca L Hand
Nurse Practitioner · Charlottesville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 18 years
- Graduated 2008
Offices
1 location · University of Virginia Physicians Group · 1,685 clinicians in this group
Hospitals listed: Uva Health Sciences Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rebecca L Hand’s office at (434) 924-8129 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Virginia Medical CenterCharlottesville, VAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of Virginia Health System, which runs 5 hospitalsHome of University of Virginia Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 2.71 (1.74 to 3.69) · 3,339 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.211, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.375, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 10 (8.1 to 12.3) · 4,614 cases, Jan 2022 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.8) · 3,280 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of Virginia Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.71 (1.74 to 3.69) · 3,339 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.211 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10 (8.1 to 12.3) · 4,614 cases | Better | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.8) · 3,280 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.65 (0 to 1.34) · 3,915 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.82 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 141.48 (107.28 to 175.69) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 265 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 672 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.2 · 476 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 5,417 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.1 to 0.43) · 12,730 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.37 (0.21 to 0.54) · 13,661 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (3.02 to 5.65) · 5,659 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.71 (1.74 to 3.67) · 5,063 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.42 (5.49 to 11.34) · 3,246 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.8 (2.85 to 6.75) · 3,317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.34 (0.12 to 2.55) · 1,516 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.45 (0.05 to 0.84) · 11,873 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 131 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.763 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.529 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.9 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 365 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 871 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 35.9 · 363 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8 · 763 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6.7 · 474 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 557 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.5) · 1,313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (9.4 to 12.9) · 1,313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 147 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 209 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,521 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Drugs they prescribed that Part D paid
$1,775
Pharmacies billed $1,775 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 43% of their Part D prescriptions (56 of 129) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
115 generic and 14 brand-name prescriptions · $1,775 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 39 | $137 | $4 |
| Baclofen | 12 | $76 | $6 |
Year by year
| 2024 | 129 | 74 | 43% (56) | 11% | $1,775 |
| 2023 | 211 | 96 | 31% (65) | None | $3,936 |
| 2022 | 217 | 109 | 35% (75) | None | $4,747 |
| 2021 | 243 | 116 | 34% (83) | 7% | $4,541 |
| 2020 | 243 | 117 | 33% (80) | None | $9,622 |
| 2019 | 316 | 144 | 31% (99) | None | $18,518 |
| 2018 | 268 | 130 | 34% (92) | None | $12,147 |
| 2017 | 274 | 139 | 39% (108) | None | $11,704 |
| 2016 | 357 | 156 | 38% (134) | None | $12,575 |
| 2015 | 294 | 121 | 35% (102) | None | $22,969 |
| 2014 | 135 | 60 | 31% (42) | 12% | $6,195 |
| 2013 | 111 | 50 | 40% (44) | 13% | $6,662 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Levetiracetam | 11 | $572 | $52 |
| Oxycodone | 47 | $273 | $6 |
| Baclofen | 22 | $257 | $12 |
2022: 6 drugs
| Naloxone | 11 | $773 | $70 |
| Levetiracetam | 14 | $409 | $29 |
| Baclofen | 26 | $390 | $15 |
| Oxycodone | 54 | $342 | $6 |
| Gabapentin | 11 | $267 | $24 |
| Hydromorphone | 15 | $120 | $8 |
2021: 4 drugs
| Oxycodone | 68 | $504 | $7 |
| Baclofen | 24 | $435 | $18 |
| Levetiracetam | 13 | $431 | $33 |
| Hydromorphone | 11 | $67 | $6 |
2020: 3 drugs
| Baclofen | 30 | $506 | $17 |
| Oxycodone | 68 | $470 | $7 |
| Levetiracetam | 14 | $346 | $25 |
2019: 6 drugs
| Baclofen | 36 | $1,609 | $45 |
| Oxycodone | 80 | $852 | $11 |
| Levetiracetam | 24 | $762 | $32 |
| Dexamethasone | 22 | $510 | $23 |
| Famotidine | 11 | $136 | $12 |
| Tamsulosin | 13 | $90 | $7 |
2018: 3 drugs
| Oxycodone | 76 | $1,260 | $17 |
| Levetiracetam | 16 | $588 | $37 |
| Baclofen | 37 | $530 | $14 |
2017: 4 drugs
| Oxycodone | 87 | $998 | $11 |
| Dexamethasone | 13 | $635 | $49 |
| Baclofen | 19 | $427 | $22 |
| Gabapentin | 12 | $304 | $25 |
2016: 8 drugs
| Oxycodone | 75 | $1,126 | $15 |
| Hydrocortisone | 14 | $568 | $41 |
| Baclofen | 24 | $501 | $21 |
| Tramadol | 35 | $253 | $7 |
| Levetiracetam | 17 | $238 | $14 |
| Hydromorphone | 12 | $156 | $13 |
| Cyclobenzaprine | 19 | $128 | $7 |
| Tamsulosin | 11 | $122 | $11 |
2015: 7 drugs
| Oxycodone | 63 | $930 | $15 |
| Dexamethasone | 11 | $355 | $32 |
| Gabapentin | 12 | $193 | $16 |
| Baclofen | 11 | $172 | $16 |
| Cyclobenzaprine | 14 | $163 | $12 |
| Tramadol | 26 | $144 | $6 |
| Lisinopril | 11 | $71 | $6 |
2014: 2 drugs
| Oxycodone | 26 | $429 | $17 |
| Tramadol | 11 | $75 | $7 |
2013: 1 drug
| Oxycodone | 21 | $276 | $13 |
Professional record
- NPI
- 1013169077
- Licence
- VA 0024168047
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 207T00000X (207T00000X)
- Mailing address
- Po Box 9007, Charlottesville, VA, 22906
- NPI first listed
- 2008-10-21
- NPI last updated
- 2023-10-10
- NPI record certified
- 2023-10-10
This is when the NPI record was last certified, not a medical board exam.